Oak Ridge Investments LLC Purchases 782 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)

Oak Ridge Investments LLC grew its position in Axon Enterprise, Inc. (NASDAQ:AXON) by 5.4% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 15,153 shares of the biotechnology company’s stock after acquiring an additional 782 shares during the quarter. Oak Ridge Investments LLC’s holdings in Axon Enterprise were worth $9,006,000 as of its most recent SEC filing.

Several other institutional investors also recently modified their holdings of AXON. Geode Capital Management LLC raised its stake in shares of Axon Enterprise by 2.0% in the third quarter. Geode Capital Management LLC now owns 1,782,828 shares of the biotechnology company’s stock valued at $710,103,000 after purchasing an additional 35,320 shares in the last quarter. Westfield Capital Management Co. LP raised its stake in shares of Axon Enterprise by 12.2% in the 3rd quarter. Westfield Capital Management Co. LP now owns 1,175,328 shares of the biotechnology company’s stock valued at $469,661,000 after buying an additional 127,769 shares in the last quarter. Champlain Investment Partners LLC lifted its holdings in shares of Axon Enterprise by 13.9% during the 3rd quarter. Champlain Investment Partners LLC now owns 682,420 shares of the biotechnology company’s stock worth $272,695,000 after acquiring an additional 83,265 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its position in shares of Axon Enterprise by 1.6% during the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 561,263 shares of the biotechnology company’s stock valued at $224,281,000 after acquiring an additional 9,090 shares in the last quarter. Finally, Groupama Asset Managment bought a new stake in Axon Enterprise in the third quarter valued at about $200,000. Institutional investors and hedge funds own 79.08% of the company’s stock.

Axon Enterprise Stock Up 1.4 %

NASDAQ AXON opened at $593.89 on Friday. The stock has a market capitalization of $45.28 billion, a P/E ratio of 153.46, a price-to-earnings-growth ratio of 5.71 and a beta of 1.04. Axon Enterprise, Inc. has a 52 week low of $247.04 and a 52 week high of $698.67. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.63 and a current ratio of 2.96. The stock has a fifty day moving average of $617.37 and a 200-day moving average of $459.99.

Wall Street Analyst Weigh In

A number of research analysts have commented on AXON shares. TD Cowen began coverage on shares of Axon Enterprise in a research note on Wednesday, January 8th. They set a “buy” rating and a $700.00 price target for the company. Needham & Company LLC boosted their price target on Axon Enterprise from $525.00 to $600.00 and gave the company a “buy” rating in a research note on Friday, November 8th. Northland Securities upped their price target on Axon Enterprise from $365.00 to $550.00 and gave the company an “outperform” rating in a research report on Monday, November 11th. JMP Securities lifted their price objective on Axon Enterprise from $430.00 to $500.00 and gave the company a “market outperform” rating in a report on Thursday, October 31st. Finally, Morgan Stanley raised shares of Axon Enterprise from an “equal weight” rating to an “overweight” rating and lifted their price target for the company from $500.00 to $700.00 in a report on Tuesday, December 3rd. One investment analyst has rated the stock with a hold rating and fourteen have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $504.92.

Insider Activity at Axon Enterprise

In other Axon Enterprise news, Director Caitlin Elizabeth Kalinowski sold 450 shares of the firm’s stock in a transaction that occurred on Thursday, January 2nd. The shares were sold at an average price of $604.07, for a total value of $271,831.50. Following the transaction, the director now directly owns 6,929 shares of the company’s stock, valued at approximately $4,185,601.03. This trade represents a 6.10 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Jeffrey C. Kunins sold 21,834 shares of the company’s stock in a transaction on Tuesday, November 12th. The shares were sold at an average price of $593.88, for a total transaction of $12,966,775.92. Following the sale, the insider now owns 154,394 shares of the company’s stock, valued at $91,691,508.72. The trade was a 12.39 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 50,545 shares of company stock worth $30,721,337 over the last 90 days. Insiders own 5.70% of the company’s stock.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.